🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 218352102
- Market Cap
- Large Cap
- IPO
- 4/14/2004 · $12.00/share
Business: Corcept Therapeutics, Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol.
Company Contact
- CEO
- Joseph K. Belanoff, MD
- CFO
- Atabak Mokari
- Headquarters
- 149 Commonwealth Drive, Menlo Park, CA 94025
- Phone
- 650-327-3270
- Fax
- 650-327-3218
- Investor Relations
- ir@corcept.com